Neurofeedback app shows promise in improving brain function in children with dyslexia
A new pilot study suggests that neurofeedback-based digital training may significantly enhance brain function in children diagnosed with dyslexia, offering fresh hope for non-invasive, long-term interventions targeting reading-related neurological challenges.
In a paper titled “Enhancing Left Hemisphere Function in Dyslexia: A Pilot Study on 14-Channel Neurofeedback With Auto Train Brain,” researchers Gunet Eroglu and Raja Abou Harb examined the effects of neurofeedback training delivered through a mobile application called Auto Train Brain. The study focused on children aged 7 to 10 with dyslexia, a neurodevelopmental disorder characterized by persistent difficulties in reading speed and comprehension despite normal intelligence.
Targeting the Brain’s Left Hemisphere
Previous neurological research has consistently linked dyslexia to functional deficits in the brain’s left hemisphere, particularly in regions associated with language processing such as the left temporal lobe. Neurofeedback—a technique that enables individuals to self-regulate brain activity through real-time feedback—has increasingly gained attention as a tool to address such deficits.
In this study, researchers analyzed gamma band entropy variance, a measure of neural signal complexity associated with cognitive flexibility and information processing. Higher entropy variance is generally understood to reflect healthier and more adaptable neural activity.
Comparing Training Intensity and Technology
The research team evaluated electrophysiological changes across 30-session and 100-session neurofeedback training programs, using two different EEG headset configurations: the EMOTIV INSIGHT (5-channel) and the more advanced EMOTIV EPOC-X (14-channel).
Findings revealed that both the duration of training and the sophistication of the headset played a significant role in outcomes. Children who completed 100 neurofeedback sessions using the 14-channel headset demonstrated the most notable improvements, particularly in the left temporal lobe. These changes point to enhanced functional neural adaptability in areas critical for language and reading.
Growing Interest in Digital Neurotherapies
The study comes amid growing global interest in digital and home-based neurotherapies, especially in pediatric neurodevelopmental disorders such as dyslexia, ADHD, and autism spectrum disorder. Recent advances in wearable EEG technology and AI-driven neurofeedback algorithms have made such interventions more accessible, personalized, and scalable.
While the authors stress that the findings are preliminary and based on a pilot sample, they argue that the results reinforce earlier evidence supporting neurofeedback’s ability to modulate brain activity in dyslexia. Larger, controlled clinical trials are now being called for to confirm the long-term educational and cognitive benefits.
A Potential Long-Term Intervention
“Our results suggest that sustained neurofeedback training, particularly with higher-resolution EEG systems, can support left hemisphere functional improvement in children with dyslexia,” the authors noted. They added that neurofeedback could complement traditional educational interventions rather than replace them.
As educators, clinicians, and parents continue to seek effective, non-pharmacological approaches to learning disorders, studies like this point to a future where brain-based digital therapies play a growing role in supporting children with dyslexia—both in clinical settings and at home. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
Influenza cases are rising sharply across Europe, placing growing pressure on hospitals and health systems in many countries, the World Health Organization (WHO) has warned.
Türkiye’s total environmental protection expenditure reached 441 billion Turkish lira in 2024, marking a sharp increase of 108.3 percent compared to the previous year, the Turkish Statistical Institute (TurkStat) said in a statement on Thursday.
A federal judicial panel on Monday ordered that a growing number of lawsuits accusing Novo Nordisk and Eli Lilly of causing vision loss be centralized before a single judge in Pennsylvania, marking a significant new phase in litigation over the widely used weight-loss and diabetes drugs.